Sir/Madam IL-4 gene polymorphism has been reported for their association with several diseases such as Graves's disease (1), subacute sclerosing panencephalitis (2) , rheumatoid arthritis (3-4), endstage renal disease (5), idiopathic thrombocytopenic purpura (6), chronic polyarthritis (7), fibromyalgia (8) , malaria (9) , transitional cell carcinoma of the urinary bladder (10), oral cancer (11), gastric cancer (12) . The human chromosomal DNA structure of IL-4 consists of four exons and map to 5th chromosome (13) . Identification of polymorphic sites in IL-4 initiated a large number of molecular genetic studies for their association with a wide range of diseases. The first of the two polymorphic sites reported in IL-4 gene were intronic repeats, GT repeat in the intron-3 and 70bp VNTR in the intron-2 (14) . In this study Mout et al 1991, used primer sequence forward 5'-TAGGCTGAAAGGGGGAAAGC-3' and reverse 5'-CTGTTCACCTCAACTGCTCC-3' for amplifying 70bp VNTR in the intron-2. Later on, another two single nucleotides polymorphic sites were reported in promoter region of IL-4, C/ T (BsmFI) transition at -590 position, C/T transition at -34 position (15) . Currently, plentiful of polymorphic markers probes are available for IL-4 gene.
The 70bp repeat polymorphism was reported to have a frequent allelic form consists of three repeats along with a rare allele of double repeats has also been described. In addition, there is a third rare allele consisting of four repeats. Few of the paper have mentioned location of 70bp repeat as intron-2 (20, 21) . However, most of the authors have cited the location of 70bp repeat as intron-3 (3, 4, 6, 7, 8, 9, 11, 12, 16, 17, 18, 19) with mentioning in the title of the paper (5, 10, 15) and interestingly quoting Mout et al., 1991 . Upon query for amplimers in the GDB database (GDB.org) also retrieved its citation position as IVS2. But, NCBI blast (ID BLASTN 2.2.17, Aug-26-2007) revealed that the forward primer location as 7671-7690bp of the intron-3 of IL-4 gene (Accession no M23442) as shown in figure 1 . We feel that it was somehow overlooked in original scientific communication that warrants attention for rectification. For adding this modification to a highly cited polymorphic site of IL-4 gene, it's better late than never!
